Introduction
It is generally accepted that platelets play a major role in the pathogenesis of several vascular disorders as myocardial infarction and arterioscle rosis (Holmsen, 1982) . Their receptors for dif ferent agonists as well as the following pathways of signal transduction offer a number of interest ing pharmacological targets e.g. phospholipases A 2 (P L A 2) and C (PLC), proteinkinase C (PK C) and adenylate cyclase (A D C ). P L A 2 of platelets is one central enzyme in the cascade of signals leading to complete aggregation (Kramer et al., 1989) .
Arachidonic acid liberated by P L A 2's of dif ferent tissues serves as a precursor of prostaglandines, leukotrienes and thromboxanes, mediators that play a central role in diseases like arthritis or inflammation (Decker, 1991) .
In the course of a screening several hundred extracts derived from submerged cultures of basi diomycetes were tested for the presence of inhibi tors of collagen-induced aggregation of bovine platelets.
In the following we describe the fermentation, isolation, structure elucidation and new biological properties of 5-hydroxy-3-vinyl-2(5H)-furanone 1 from fermentations of C alyptella sp. 9039.
Material and Methods

G eneral
IR and U V spectra were measured with a Bruker ISF 48 and a Perkin-Elmer Lambda 16 U V/VIS spectrometer, respectively. For analytical H PLC a Hewlett-Packard 1090 series II instru ment was used.
All N M R spectra were recorded on a Bruker AM X500 spectrometer working at 500.14 M H z for 'H and at 125.77 M H z for L'C. The solution of 5-hydroxy-3-vinyl-2(5H)-furanone (1) was 24 m M in D 2 0.
High resolution mass spectra were measured with a Finnigan M AT 312 spectrometer (ion en ergy 70 eV, source temperature 250 °C, acc. volt 3 kV).
For LC coupled thermospray mass spectroscopy (LC-TSPMS) a Finnigan M AT TSQ45 instrument was used (source temperature 140 °C, nebulizer temperature 140 °C, repeller 130 V; MS/MS: colli sion gas N 2, collision energy 5.1 V; chromato graphic conditions; HPLC: LiChropher RP 18, 10 |im, Merck, column 250x4 mm, water-methanoltrifluoroacetic acid (85:15:0.05), flow rate 1.2 ml/ min).
C alyptella sp. strain 9039 C alyptella sp. strain 9039 was isolated from the Reprint requests to Prof. T. Anke.
sPore Print of a fruiting body collected on wood Telefax; (0631) 2052999. in Mossman/Cairns, Australia. The specimen 0939-5075/95/0500-0403 $ 06.00 © 1995 Verlag der Zeitschrift für Naturforschung. A ll rights reserved.
showed all characteristics of the genus Calyptellci (Singer, 1986 ) (Agaricales, Tricholomataceae, Collybieae), the species, however, could not be iden tified. Herbarium specimen and mycelial cultures are deposited in the culture collection of the LB Biotechnologie, University of Kaiserslautern. For maintenance on agar slants the fungus was grown on Y M G medium (yeast extract 0.4 %, malt extract 1.0 % , glucose 0.4 % , pH 5.5).
Ferm entation an d isolation o f 5 -h ydroxy-3-vin yl-2(5H )-fu ran on e (1)
Fermentations were carried out in a Biostat U fermentor equipped with a MFCS system (B. Braun Biotech) containing 100 1 of Y M G medium at 135 rpm, 20 liters air/min and 22 °C. The content of oxygen in the medium and C 0 2 and oxygen in the exhaust were determined on-line. During fer mentation and in fractions during chromatography the content of 1 was measured by analytical HPLC (LiChrosorb RP-18, 5 j.im, Merck, column 4x125 mm; 1.5 ml/min, 40 °C; H 20 : M e O H 0 100% in 20 min; retention time 4 min) and by platelet aggregation assay.
After 70 hours the oxygen content of the me dium was limited by reducing the stirrer speed to 90 rpm and the aeration to 4 litres air/min. After 116 hours of fermentation the mycelia were sepa rated from the culture fluid by filtration. 1 was removed from the culture fluid (95 1) by adsorp tion to HP21 resin (Mitsubishi) and eluted with acetone. The crude extract (12.86 g) was subjected to gel permeation chromatography (LiChrogel PSI, 7 (_im, Merck, column 250x25 mm, elution with 2-propanol) resulting in 2.14 g of enriched product containing approximately 25 % 1. Pure 1 was obtained by isocratic H P L C (LiChropher RP 18, 10 [im, Bischoff, column 250x20 mm) using water-methanol-trifluoroacetic acid (85:15:0.05); retention time 26 min.
B iological assays
The platelet aggregation assay and the test for inhibitory effects on the synthesis of macromole cules was carried out as reported previously (Lorenzen et a l., 1994). Further tests as for cyto toxic effects, hemolytic activity and the antimicro bial activity in the serial dilution assays are de scribed elsewhere (Zapf et al., 1995). The inhibition of phospholipases A 2 from snake venom was tested as described by Nieuwenhuizen et al. (1974) . The tests for inhibitory effects of 1 on hu man synovial phospholipase A 2 human pancreatic phospholipase A 2 and human cytosolic phospho lipase A 2 were performed according to Scheuer et al. (1989) and to Rodewald et al. (1994) .
Results and Discussion
Ferm entation a n d isolation Fig. 1 shows a typical fermentation of C alyptella sp. 9039 in 100 liters of YM G-medium. After 186 hours the content of 5-hydroxy-3-vinyl-2(5H)-furanone 1, as detected by analytical H PLC, reached a maximum of 6.5 mg/liter and 1 was iso lated as described in the experimental section.
5-H y d ro x y -3-vin y l-2 (5 H )-fu ran on e (1)
The highly unstable 5-hydroxy-3-vinyl-2(5H)-furanone (1 ) was obtained as slightly yellowish oil soluble in methanol, acetone or ethyl acetate, and moderately soluble in water. A t room temperature I, content of pletely insoluble polymer. Depending on the pH the 5-hydroxy-3-vinyl-2(5H)-furanone ring of 1 opens to l a , the predominant species in neu tral methanol. The physico-chemical data of 1 (Table I) prove that the compound isolated from C alyptella sp. 9039 is identical to 5-hydroxy-3-vinyl-2(5H)-furanone, first isolated by Els et al. (1958) from a Streptom yces strain and published as antibiotic PA 147 (Els et al., 1958) . 1 is the first metabolite isolated from a C alyptella species.
From other authors a synthesis of 1 (Black et al., 1973) starting from prop-2-ynyl vinyl ether has been described. It is intersting that the hy droxy furanone moiety of 1 also occurs in the structure of the well known P L A 2-inhibitors manoalide (2) and luffariellolide (3) which have been isolated from several marine sponges (Silva et al., 1980; .
B io lo g ica l activities
The inhibitory effect of 1 on the thrombin-induced aggregation of bovine platelets is shown in Fig. 2 . A complete inhibition of aggregation was obtained by 50 ng/ml (396 jam) of 5-hydroxy-3-vinyl-2(5H)-furanone, the IC 3 0 value (30 % inhi bition) of 1 was determined to 9 [ig/ml (71 ^m). The first, reversible phase, was hardly affected, the second irreversible phase of aggregation was in hibited by concentrations above 10 |ig/ml (79 [.i m ) . Figure 3 shows the influence of 1 on the throm bin-induced aggregation of human platelets. The Table I Ti me (m i n) 
a 30% inhibition of aggregation. h Thromboxane A 2 analogue (U pjohn).
-Inducer not suitable.
Ti m© (ml rO The effects of 1 on the aggregation of human and bovine platelets stimulated with different in ducers are compared in Table II . 1 inhibited pref erentially the aggregation induced by thrombin and arachidonic acid (A A ). In the latter case A A can act both as stimulator of PLA 2 and substrate for cyclooxygenase. The IC 3 0 values of 1 for the other inducers are significantly higher. A specific interference of 1 with one of the receptors for the agonists seems unlikely.
The receptor for thrombin couples directly to P L A 2 (Lapetina et al., 1990) . Therefore an inhibi tion of membrane bound P L A 2 of platelets seemed possible. If this were true, 1 would in terfere with the stimulatory activity of A A under the the chosen conditions. W ith this in view, the inhibitory activity of 1 was tested against P L A 2's from N a ja m o s a mb iq a e (type I), C ro ta lu s a tro x (type II), U937 cells (type II), human pancreas (type I) and human synovial fluid (type II). The IC 5 0 values presented in Table III show a preferential inhibition of human synovial P L A 2 at nanomolar concentra tions, a value which is in good accordance with the inhibition of P L A 2's (bee venom, cobra venoms, human synovial fluid) observed with manoalide (2) and luffariellolide 3 O th e r b io lo g ic a l a c tiv itie s
Els et al. had reported antibacterial (S ta p h y lo
c o c c u s a u reu s, X a n th o m o n a s o r y z a e ) and cytotoxic (HeLa) effects for PA 147 1 (Els e t a l., 1958) . In mice bearing Ehrlich carcinoma a pronounced antitumor activity was observed. The cytotoxic activities of 1 against BHK-, HeLa S3-, L 1210-, H L 60-and U 937-cell cultures were tested as described previously (Zapf e t al., 1995) . A lytic action of 1 on BHK-and H L 60-cells could be observed at concentrations higher than 2 0 \igl ml (158 ["im), while HeLa S3 cells were affected by concentrations starting from 50 [ig/ml (396 [^im) (Table IV ) . With L 1210-and U 937 cells a weak inhibition of cell growth at concentrations of 100 ^g/ml (793 ("im ) was observed.
The incorporation of 1 4 C-labeled thymidine, uri dine and leucine into D N A , R N A and proteins of H L 60 cells was tested as described previously (Lorenzen e t a l., 1994). Figure 4 shows a preferen- Table IV The antifungal and antibacterial effects of 5-hydroxy-3-vinyl-2(5H)-furanone were determined in the serial dilution assay ( Table V) . The organisms most sensitive to 1 were the yeast N. coryli and the bacteria M. liiteus and S. th yp h im u riu m , whereas other bacteria and fungi were less sensitive.
In the "pour-plate-test" for mutagenicity (with out microsomes) with four strains of S. th yp h im u rium (TA 97, TA 98, TA 100 and TA 102) (Ames et al., 1975) no increase of the number of revertans 408 K. Lorenzen et al.
could be observed at concentrations from 1 -2 0 [i.g/ml (8-158 |im) of 5-hydroxy-3-vinyl-2(5H)-furanone.
In conclusion 1 appears to be a highly potent and selective inhibitor of human synovial phospholipase A 2. The selectivity towards this enzyme is much higher as compared to manoalide (2 ) and luffariellolide (3).
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